Helping patients with rheumatoid arthritis transition from biologics to other drugsMonitoring algorithm for pharmacists facilitates switching from originator biologics to other originator biologics, biosimilars or Janus kinase inhibitors. How to optimize bone health in men receiving androgen deprivation therapyCanadian Urological Association provides recommendations for maintaining bone health in men with prostate cancer receiving ADT Help prevent methotrexate toxicity from unintentional dosing errors Accidental duplicate ingestions by patients and healthcare professional errors are the most common unintentional errors. Review identifies slip ups that lead to methotrexate toxicity from unintentional dosing errors Accidental duplicate ingestions by patients and healthcare professional errors are the most common unintentional errors. Do patients practicing sun-protection behaviours need to worry about negative effects on bone health? A new study finds no decrease in bone mineral density or increase in osteoporotic fractures. Incidence of total joint arthroplasty in rheumatoid arthritis declines in biologics era BC study finds significant reductions in total hip and knee replacements after introduction of biologics in patients with rheumatoid arthritis. Canadian studies to examine COVID-19 vaccine efficacy in cancer, immunodeficiency and more The Ottawa Hospital launches four national studies funded by Canada’s COVID-19 Immunity Task Force. New U.S. guidance on pharmacologic management of rheumatoid arthritis Recommendations for use of various types of disease-modifying antirheumatic drugs and glucocorticoids, including use in certain high-risk populations. Arthritis patients and COVID-19 vax quiz New American College of Rheumatology guidelines for management of gout Provide advice on optimal use of urate-lowering therapy, treatment of gout flares, lifestyle and other medications First Previous 9 10 11 12 13 Next Last
